24小时热门版块排行榜    

查看: 446  |  回复: 2
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

也到

木虫 (小有名气)

无欲无求

[求助] 求linifanib最新临床情况 已有1人参与

求linifanib最新临床情况,最好包括临床类型及几期
还有这种药物的发展前景
回复此楼
不知所措
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

ovk999

金虫 (小有名气)

【答案】应助回帖

感谢参与,应助指数 +1
AbbVie is developing linifanib, an orally active multi-targeted receptor tyrosine kinase inhibitor, for the treatment of cancer, including non-small cell lung cancer, breast cancer, colorectal cancer, renal cancer and hepatocellular carcinoma. Linifanib was being developed in collaboration with Genentech; however, development later reverted to Abbott. Linifanib acts as both a vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor tyrosine kinase inhibitor. It has been shown to stop disease progression by limiting tumour blood-flow. Linifanib is hydrophobic, but is oxidised in the body to A 849529, a hydrophilic metabolite that includes both carboxyl and amino groups. Linifanib is in phase II development for breast, renal, colorectal and non-small cell lung cancer. The compound was being investigated in a phase III trial for hepatocellular carcinoma, but the trial has been terminated.

» 本帖附件资源列表

  • 欢迎监督和反馈:小木虫仅提供交流平台,不对该内容负责。
    本内容由用户自主发布,如果其内容涉及到知识产权问题,其责任在于用户本人,如对版权有异议,请联系邮箱:xiaomuchong@tal.com
  • 附件 1 : Linifanib-临床开发情况.docx
  • 2014-08-20 14:47:24, 87.78 K
3楼2014-08-20 14:46:14
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 3 个回答

fbifbeaifb

新虫 (初入文坛)


这个只能是汤森数据库才能查到了
2楼2014-08-20 10:46:28
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +4 uKOSCocCb6Fm 2026-11-13 4/200 2026-11-16 10:11 by K7HMGGdOpylw
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 SX5mJmPWDfOO 2026-11-13 3/150 2026-11-15 08:18 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 SX5mJmPWDfOO 2026-11-13 4/200 2026-11-15 07:34 by xSrQNSSjcgoX
[公派出国] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 uKOSCocCb6Fm 2026-11-12 7/350 2026-11-15 03:43 by xSrQNSSjcgoX
[论文投稿] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 uKOSCocCb6Fm 2026-11-12 10/500 2026-11-15 02:15 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 uKOSCocCb6Fm 2026-11-12 9/450 2026-11-15 02:04 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-15 00:27 by Equinoxhua
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +4 YHiw1gou1Eda 2026-11-10 7/350 2026-11-14 22:44 by Equinoxhua
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +5 YHiw1gou1Eda 2026-11-10 8/400 2026-11-14 22:20 by Equinoxhua
[考博] 27博士申请 +5 白白白ly 2026-11-09 5/250 2026-11-13 05:01 by wlf1982
[教师之家] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +6 czAiolzR0IJC 2026-11-10 6/300 2026-11-12 16:55 by zzy933268
[考博] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +3 Z7qfCsdIiD1T 2026-11-10 5/250 2026-11-12 11:25 by HajghKOMynmz
[教师之家] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 Z7qfCsdIiD1T 2026-11-10 9/450 2026-11-12 11:22 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +5 czAiolzR0IJC 2026-11-10 6/300 2026-11-12 11:03 by HajghKOMynmz
[基金申请] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +4 czAiolzR0IJC 2026-11-10 8/400 2026-11-12 11:00 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:36 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +7 FChKX8meu1ds 2026-11-09 12/600 2026-11-12 09:43 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +8 zSbvVX9JFl9J 2026-11-09 12/600 2026-11-12 09:21 by HajghKOMynmz
[考研] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 cdqGD6ftHmbl 2026-11-11 3/150 2026-11-12 07:53 by HajghKOMynmz
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 zSbvVX9JFl9J 2026-11-09 8/400 2026-11-12 04:57 by 9fOTqj074tIg
信息提示
请填处理意见